Wearable Clinical Articles & Analysis
19 news found
Clinicians at Ardent’s BSA Hospital in Amarillo, Texas, began using the BioButton wearable device and BioCloud analytics engine in September to automate the collection of inpatient vital signs in general care units and increase both patient and clinician satisfaction. ...
The BioButton® medical grade wearable device will be used for commercial spaceflight research programs and notably during the upcoming five-day Polaris Dawn mission. ...
BioIntelliSense, a continuous health monitoring and clinical intelligence company, today announced its acquisition of AlertWatch®, an FDA-cleared, clinically proven patient monitoring solution. ...
The ZEUS System is the AI algorithm and solution component of the Zio® Watch: a sensor-based wearable for noninvasive, clinical grade, long-term continuous monitoring for atrial fibrillation (AFib). ...
Neurolief Ltd., a neurotechnology innovator, today announced enrollment of the first patient in its pivotal clinical study evaluating Relivion® DP for the treatment of major depressive disorder (MDD). ...
The FDA marketing clearance is based on the results of a multi-center, prospective, randomized, double-blind, placebo-controlled clinical study. Forty-six percent (46%) of the patients in the active group reached complete pain freedom compared to only 11.8% of patients in the control group. ...
By using Biobeat’s medical-grade wearables we are able to enhance clinical trials with vital signs collection to generate real-world evidence remotely and conveniently from the patient’s home. Our platform supports decentralized clinical trials and significantly reduces the logistics burden and the trial ...
The real-world, open-label analysis presents clinically meaningful data on the prevention of migraine, including responder rate, reduction in monthly migraine days and reduction in medication use for those with high-frequency episodic or chronic migraine. The eCOT-NS System is a wearable digital therapeutic neurostimulation system, intended to treat migraine and ...
Neurolief, a neurotechnology innovator, today announces the publication of the SP301 study in the Pain and Therapy Journal that demonstrates the safety and efficacy of Relivion MG, Neurolief’s CE-marked and FDA cleared wearable neuromodulation system for at-home treatment of migraine with remote physician monitoring. ...
Fashionable, discreet and stylish, the CART-I (Cardio Tracker) ring uses advanced technology to consistently monitor the wearer’s heartbeat. The wearable technology is comfortable and easy to use and can become an integrated part of the buyer’s lifestyle. ...
BySky Labs
eNOfit™, Third Pole’s novel nitric oxide mobile-wearable device designed to provide “on-the-go” treatment for patients suffering from severe COPD and ILD, to enter clinical trials in the second half of this year Funding will support device optimization and clinical trials; Pivotal trial data expected in the second half ...
"Scott's tenure at the helm of BCBSA, enables him to provide unique strategic guidance as we seek further reimbursement coverage for our clinically-validated migraine treatment wearable, Nerivio®." Selected by President George W. ...
The FDA marketing clearance is based on the results of a multi-center, prospective, randomized, double-blind, placebo-controlled clinical study. Forty-six percent (46%) of the patients in the active group reached complete pain freedom compared to only 11.8% of patients in the control group. ...
This new version includes certain improvements in the prosthesis and the wearable system based on clinical experience gained in the PIVOTAL study. ...
ByCarmat
About Neurolief Dedicated to bringing relief to patients suffering from chronic neurological and neuropsychiatric disorders, Neurolief is creating a digital therapeutics platform of wearable clinically-proven neuromodulation solutions. This technology, which is made to be worn like a headset, is intended to offer highly effective, safe treatment options that ...
“The Relivion, with its adaptive stimulation channels, targets major neural pathways responsible for migraine, thereby creating a synergistic neuromodulatory effect that maximizes the clinical benefits. “This may explain why it is the only neuromodulation technology that was able to demonstrate statistically significant results for complete freedom of migraine ...
” Ninety percent of patients with major depressive disorder who had not sufficiently responded to previous pharmaceutical treatment showed improvement in depression rating when using Relivion®DP, based on an open-label clinical study. In the same study, 37% of patients reached full remission from their depressive episodes. ...
“Supporting this is the fact that our clinical results speak for themselves with unprecedented success in precise measuring, to a level of 99%, of heart arrhythmias using a wearable medical wristwatch, as part of a clinical trial conducted in three medical centers in Israel and ...
Founded in 2015, Flosonics Medical is a Sudbury-based company that develops and commercializes wearable sensors to improve the clinical management of critically ill patients. To help during the pandemic, the venture-backed startup developed a wearable Doppler ultrasound device capable of providing vital information about a COVID-19 ...